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INTRODUCTION provide medications that are highly effective in 
killing the parasite in a short time and restoring the 
Africa bears the greatest burden of  the malaria death patient to sound health. One of  the main goals of  
5toll with an estimated 30% of  all recorded deaths Roll Back Malaria  is to provide at least 60% of  those 
during pregnancy attributed to malaria infection. suffering an attack of  malaria with prompt access to 
Malaria is also known to cause about 300-500 million treatment within 24 hours. It is therefore important 
1,2cases of  acute illness each year.  The disease is that a timely access to antimalarials by all groups of  
highly endemic in Nigeria and is responsible for 29% people, even the poorest in the community is 
of  childhood deaths, 25% infant mortality and 11% actualized.  World Health Organisation (WHO) and 
3
maternal mortality. Management Sciences for Health (MSH) defined 
Artemisinin Combination Therapy (ACT) has various components of  access to medicines as 
now become the first line drug for treatment of  physical availability, affordability, geographical 
6uncomplicated malaria and ACTs have been proven accessibility and acceptability to the patient.  
4
to be highly effective against malaria.   Since Barriers to access can develop along anyone of  these 
7elimination of  malaria has not been achieved; the component parts.    Poor supply chains, weak stock 
key objective in dealing with the disease has been to 
ABSTRACT 
Background
The attainment of the 6th Millennium Development Goal to halt and reverse the effects of malaria and other 
diseases by 2015 depends on the accessibility of Artemisinin Combination Therapy (ACT) which is now the 
first line antimalarial therapy for uncomplicated malaria.  The main Objective of this study was to assess the 
availability and affordability of ACTs in Secondary Health Care (SHC) facilities in Lagos State and community 
pharmacies located within 200 meters of these facilities.
Method
Two SHC facilities each were randomly selected from four (4) geographical zones and the only one (1) in the 
fifth zone was selected, making a total of nine (9) facilities which were surveyed. The eleven (11) community 
pharmacies located within 200 meters of these health care facilities were also used for the study. A modified 
HAI was used for data collection on medicine price and availability was used for the study.
Results
ACTs (artemisinin/lumefantrine) were prescribed 90% of the time as first line antimalarial. About thirty seven 
percent (37.5%) of the hospitals did not have the drug in stock at the time of visit and drugs had been out of 
stock for upward of three weeks. Private partnership pharmacies do not stock antimalarials as a matter of 
policy, since the drugs are supposed to be obtained free from the hospital. This first line antimalarial cost about 
six hundred and forty naira (N640) in the private community pharmacies.
Conclusion
ACTs are not always available in the hospitals in Lagos State; patients therefore depend on community 
pharmacies and patent medicine stores for their ACT supply. Since 93.9% of Nigerians live in subjective 
poverty, the cost of first line ACT antimalarial remains unaffordable and inaccessible.
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management practices, and inadequate lead-time hospital. However they are not permitted to stock 
planning threaten the regular availability of  drugs in antimalarials because these drugs are supposed to be 
8 , 9 supplied free to patients. Eleven (11) Community the public health system.  In addition, 
pharmacies found within 200 meters from the unpredictable flow of  funds in many countries, 
selected health institutions were also surveyed and combined with inadequate distribution from central 
included in the study.warehouses to peripheral points of  care, lead to 
unavailability and inaccessibility of  these drugs at 
Data Collection Tools  the points of  need. Physical availability of  ACTs at 
the service points may sometimes be an issue as 
A modified version of  the WHO/HAI standardized 
observed in the studies carried out in Kenya where a 
questionnaire for data gathering on medicine 
quarter of  public health facilities had none of  the 
availability and prices was pretested and 
nationally recommended ACTs in stock and three 
administered to the hospital pharmacists and 
quarters lacked the full range of  weight specific 
community pharmacies to gather data on prices and 10packs required.  
availability of  ACTs. The community pharmacies 
were surveyed as alternative sources of  drugs within Prescribers also have a role to play in improving 
the vicinity of  the health institution.access to ACTs.  A survey carried out in 2006 by 
Oreagba et al found that though 59.2% of  
Adherence of  prescribers to National policy 
prescribers in Nigeria reported a favorable 
guidelines on malaria treatment and prescription 
disposition to the change to ACT as first line 
patterns were assessed through prescription sheets.  
antimalarial, their prescribing habits did not reflect 
Information on stock-out of  ACTs and stock-out 
the favourable disposition. Only 5.9% of  malaria 
duration was obtained from stock cards. Three ACT 
prescriptions at the time of  survey had ACTs. By 
types as recommended in the National Treatment 
2008, the workers found a gradual increase in the 
Guidelines were used as prototype for this study. 
prescribing of  ACTs in most health facilities in the 
T h e y  a r e  A r t e m i s i n i n / L u m e f a n t r i n e ,  11
country.
A r t e m i s i n i n / A m o d i a q u i n e ,  a n d  
Artesunate/Artemeter injection. Ethical approval The goal of  this study was to determine the 
for the work was obtained from the Lagos State availability and affordability of  the current first line 
Health Management Board.antimalarials, ACTs, to the Nigerian populace using 
Lagos State as a representative sample.  The 
objective of  the work was to determine the 
availability of  first line ACTs in secondary health RESULTS
institutions and in community pharmacies located 
200 meters within the secondary health care The data in Table I shows there is a state antimalarial 
institutions studied.  METHODS Study Center - policy in Lagos state. The policy caters for all 
The study was carried out in Lagos State, Nigeria. resident of  Lagos state to get free antimalarial 
There are sixteen secondary health facilities in the treatment in all public health facilities. In Table II, 
state dispersed within its five geographical divisions. 90% of  prescriptions for malaria treatment had 
Two institutions were randomly selected from each ACTs while 10% had other antimalarials especially 
of  the four geographical zones with more than two Suphadoxine/Pyrimethamine combination which is 
secondary health facilities while the only secondary used as first line drug for Intermittent Preventive 
health facility in the fifth zone was automatically Treatment (IPT) during the second and third 
included in the study, making nine (9) institutions. trimesters of  pregnancy.
Each facility has a Joint Venture Pharmacy (JVP). 
The JVP is a private pharmacy attached to the 
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On frequency of  stock-outs for ACTs and stock – were not frequent.  From the store records, 10% of  
out duration, 70% of  respondents reported frequent the health care facilities had stock-outs that lasted 
stock-outs which was attributed to the large number for up to 3 days; 70% had stock-outs that lasted up to 
of  patients being attended to on a daily basis. The 3 weeks; and 20% had stock-out that lasted up to 3 
remaining 30% had stock-outs but the stock-outs months (Fig 3).
STATE ANTIMALARIAL MEDICINE POLICY FREQUENCY PERCENTAGE% 
YES 100 100
NO 0 0
NOT SURE 0 0 
PATIENT FOR FREE ANTIMALARIALS 
Children under 5yrs,pregnant women, elderly 
person
Poor patients, children under 5yrs,older children
Poor patients, children under 5yrs, pregnant 
women, elderly person.
 Poor patients, children under 5yrs, older 
children, pregnant women, elderly persons.
 
100 100 
   
 
Table I: State Antimalarial Policy










Table II:  Antimalarial prescription for uncomplicated malaria
Figure 1: Adherence to new treatment guidelines for malaria
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Figure 2: Stock out frequency of  antimalarial in the secondary institutions
Figure 3: Availability of  ACTs in the secondary health care institutions
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Figure 4: Availability of ACTs in community pharmacies
At the time of  visit, six of  the nine institutions had visit (Fig 3). The community pharmacies however 
the first line ACT (artemisinin/lumefantrine) in stocked the entire range of  antimalarials including 
stock, six (6) had artemisinin/amodiaquine and five chloroquine which is no longer on the Nations 
had artesunate/artemeter injection. They had these treatment guideline. Amodiaquine was also in stock 
alongside one or two other antimalarias. Only one in the community pharmacies as single dose 
facility (Orile-Agege) had the (3) types at the time of  medication (Fig.4).
I n  t h e  c o m m u n i t y  p h a r m a c i e s ,  available in community pharmacies cost N125.56, 
Artemisinin/Lumefantrine cost about N640.00 a m o d i a q u i n e  N 1 5 0 . 0 0  a n d  
while Artemisinin/Amodiaquine cost N658.82. sulphadoxine/pyrimethamine N150.00 per dose.
The antimalarial chloroquine which was still 
DISCUSSION access to medicines. The Lagos State government in 
an attempt to make ACTs accessible instituted the 
The prescribers in Lagos state secondary health Eko Free Drug Programme which provides free 
facilities have adapted quite well to the new malaria treatment for the inhabitants of  the state 
guideline on malaria management. This study regardless of  age through primary and secondary 
4records a 90% prescription of  ACTs for health facilities.  There are 16 secondary health 
uncomplicated malaria. This is an impressive facilities that are well dispersed in the state to allow 
improvement on the 5.9% reported in an earlier for easy access. This program was supposed to 
11study.  The key to accessibility to ACTs is in address the challenges of  accessibility. However, this 
availability and affordability. A drug is affordable if  study reveals that in spite of  the free drug program, 
it cost 10 cents or less per day for the complete availability of  the first line antimalarials in the 
treatment and WHO considers physical hospitals is still a big challenge. The drugs are 
availability, affordability, geographical access and sometimes not available in the health facilities with 
acceptability to the patient as vital components of  70% of  the hospital surveyed, experiencing stock-
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out lasting for as long as three (3) weeks.  The and chloroquine for the treatment of  malaria. This 
malaria situation analysis carried out by Federal is contrary to the WHO guidelines for malaria 
Ministry of  Health in 2000 reported that 85% of  treatment and it is a drawback to the achievement of  
health facilities in the rural areas had stock-outs of  improved and efficient malaria treatment.
13
antimalarials.  Medicine availability has been cited 
All the community pharmacies selected for the as a key determinant of  access to and utilization of  
14,15 s tudy (100%) had the f i rs t  l ine  ACT health services  and indeed a measure of  quality 
16 ( a r t e m i s i n i n / l u m e f a n t r i n e )  a n d  of  care.
artesunate/artemeter injection while 90.9% had 
artemisinin/amodiaquine in stock at the time of  A study carried out in Enugu State, South Eastern 
visit. Since these community pharmacies are just 200 Nigeria showed that 88.8% of  public health 
meters away from the hospitals, the patients have f a c i l i t i e s  h ad  ACTs,  and  83 . 3% had  
the choice of  going to these pharmacies to source artemeter/lumefantrine available at the time of  
17 their ACTs. The price of  medicines is generally not visit.     Forty four percent (44.7%) of  private 
regulated in the community pharmacies and patent health facilities had ACTs and 36.8% had 
medicines stores in Nigeria. The survey price of  artemeter/lumefantrine at the time of  visit.  This 
ACTs in the community pharmacies showed that shows a relatively high degree of  availability of  
the first line ACT (Artemisinin/lumefantrine) costs ACTs in health institutions in this Eastern State. 
an average of  N640 for complete treatment. Lagos State however had lower availability since 
Although N640 may not seem much to save a life, it seventy percent (70%) of  the institutions reported 
is however expensive and unaffordable in a country various degrees of  stock-outs of  ACTs at the time 
18 where 60.9% of  the populace live in absolute of  the visit. A study carried out in Tanzania  found 
poverty, 61.2% live below $1(N150) a day and 93.9% that since the change in the antimalarial 
20 9
live in subjective poverty.  Cameron et al  had management policy and by extension the first line 
reported an average of  65% availability with drug for malaria, all public health care facilities had 
unaffordable prices in the private facilities in the low a good stock of  ACTs while the stocking in 
and middle income countries.  They therefore community pharmacies reduced. A contrasting 
concluded that constraints to access to medicine at situation was seen in Ghana, the antimalarials 
public health facilities are mainly issues of  supply recommended in the health policy were not readily 
while affordability is the major challenge with available in the most accessible community 
19 private facilities. pharmacies.   Thus the situation of  stock-out in 
government hospitals at any time, for any reason 
The reality in Lagos State is that community 
and for any duration leaves the patients with the 
pharmacies are well stocked with both ACTs and 
only option of  sourcing ACTs from community 
other antimalarials. The continuous stocking of  the 
pharmacies or patent medicine stores within the 
phased out antimalarials by community pharmacies 
vicinity of  the hospital. The treatment which would 
is a hindrance to the effectiveness of  the new 
have been free ends up costing the patients some 
malaria treatment policy. The community 
amount of  money.
pharmacies never run out of  stock of  the other 
antimalarials since they are waiting to serve patients In line with the WHO guideline of  treating malaria 
4 who present with such prescriptions from with ACTs as first line drugs,  other antimalarials 
prescribers who did not adhere to the guideline of  were not available in the Lagos state government 
prescribing ACTs or patients who choose to self  hospitals except sulphadoxine/pyrimethamine 
medicate. If  ACTs are not readily available in the which is used as intermittent preventive treatment 
public hospitals in Lagos state and they are not in pregnancy. In Enugu as at 2010, the public health 
affordable from the private community pharmacies, facilities still used sulphadoxine/pyrimethamine 
then accessibility of  ACTs for malaria treatment in 
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Lagos State remains a figment of  the imagination. Venture Pharmacy, a Private-Public institution for 
improved supply of  drugs within Lagos State 
This study also reveals that 101 patients are seen hospitals.  Appropriate price regulations/subsidy 
daily in each of  these hospitals for malaria treatment will however be required to ensure affordability. It is 
leading to an estimated 48,000 patients per month expected that the state hospitals would ensure that 
being managed by secondary health facilities alone, ACTs are well stocked and adequate measures put in 
not counting the primary health institutions and the place to avoid stock-outs. Accessibility to first line 
tertiary hospitals located within the state. This large antimalarial drug remains a challenge within the 
number may explain the stock-out syndrome. state.  
Nevertheless, because Nigeria is within a malaria 
endemic region, proper planning ought to be put in 
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